Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy
about
sameAs
Sarcoglycan subcomplex expression in normal human smooth muscleCandidate-gene testing for orphan limb-girdle muscular dystrophiesPossible molecular mechanisms underlying age-related cardiomyocyte apoptosis in the F344XBN rat heartThe Dystrophin Complex: Structure, Function, and Implications for TherapyHigh-resolution array CGH clarifies events occurring on 8p in carcinogenesisDifferential expression of six genes and correlation with fatness traits in a unique broiler populationThe CC genotype of the delta-sarcoglycan gene polymorphism rs13170573 is associated with obstructive sleep apnea in the Chinese population.Secondary coronary artery vasospasm promotes cardiomyopathy progression.Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse modelsSarcoglycanopathies: molecular pathogenesis and therapeutic prospectsA novel isoform of delta-sarcoglycan is localized at the sarcoplasmic reticulum of mouse skeletal muscle.Diagnostic immunohistochemistry in neuromuscular disorders.The association of caveolae, actin, and the dystrophin-glycoprotein complex: a role in smooth muscle phenotype and function?Copy number variations associated with obesity-related traits in African Americans: a joint analysis between GENOA and HyperGEN.Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.Cell-matrix interactions in muscle disease.Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.Costamere proteins and their involvement in myopathic processes.ABC of multifaceted dystrophin glycoprotein complex (DGC).Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathyMyoclonus dystonia and muscular dystrophy: ɛ-sarcoglycan is part of the dystrophin-associated protein complex in brain.Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.Expression of sarcoglycans in the human cerebral cortex: an immunohistochemical and molecular study.No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations.Skeletal muscle contractile properties in a novel murine model for limb girdle muscular dystrophy 2i.Expression analysis of the SG-SSPN complex in smooth muscle and endothelial cells of human umbilical cord vessels.
P2860
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
P248
Q24302925-9281B4FF-3563-485D-A9AF-04FB8E67839DQ24633227-2B3F734F-C257-42D7-8A27-0CEC0BB2102AQ28566913-1429A654-B9F6-4826-A6AD-C132680AE7FDQ30376293-D9F6AB7C-6128-4C0D-94DE-C91240A8C6CDQ33374399-CA011354-BAE6-41E4-84B6-F79FF1E4A347Q33632745-C8CFC394-DA42-4F66-9DE4-0CF325AD5FD3Q34633751-CC4EC986-9E8D-4D5A-BC29-B5BB2403547FQ35096094-11C60E62-F1CD-4952-BBA4-CBBD93488B3AQ35688598-C8E20083-F988-454E-967D-8C8DA0F37630Q35758335-416EF13A-79D8-45A5-B095-553AB07D6083Q35951670-DE0D170F-4363-4E68-8E53-E778EE53B259Q36012956-7EB2372A-9269-4B8C-A417-5196ABD6EF46Q36333425-67198F3A-09A9-4ADD-A037-58A1D24BFE41Q36356698-62696F77-77A0-4DF6-993E-4EA78B7EEC51Q36902560-0D067790-118F-4E1C-9DD1-E686ABDA2A1AQ37907409-11736916-E974-40FA-A2EC-32765A4B2CB9Q37944530-932A11BA-5BCD-4656-937D-34DD16609B67Q38240078-F888B45C-4994-437B-9408-60E228A9BBA5Q38531654-3C9C3E99-B1DE-41EB-A0E2-485BC0184886Q39278570-2F6AE896-7B12-4DA7-BA44-9FC14B15243AQ40613995-5134F6B8-C989-4C64-BF6C-0F4EE95D87E6Q41878236-2216B5AA-881E-4CC7-96FE-E356E6746D06Q41906700-9F2E374B-CAB7-470E-AAC4-B1D1232DE207Q42508713-2624B586-5991-47F1-8FAF-3534F46C1795Q46691080-F79A757D-F010-44AF-89BA-45FAB874E4B3Q47874181-1FA0D0F8-4CAE-492C-9CE3-8F436D65533EQ54690459-15641E1A-21EB-4933-836D-862E3AD699CE
P2860
Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@ast
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@en
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@nl
type
label
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@ast
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@en
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@nl
prefLabel
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@ast
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@en
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@nl
P2093
P921
P3181
P356
P1476
Zeta-sarcoglycan, a novel comp ...... reduced in muscular dystrophy
@en
P2093
Elizabeth M McNally
Matthew T Wheeler
Sara Zarnegar
P304
P3181
P356
10.1093/HMG/11.18.2147
P407
P577
2002-09-01T00:00:00Z